Cell Factor™
Now available at Hydration By Lisa: The ultimate longevity protocol delivering the “end product” of regeneration. A clinically engineered, DNA-free foundation, designed to reset cellular receptors and restore signaling precision.
The Product, Not the Factory
Cell Factor delivers the “end product” of regeneration not the factory that makes it. Unlike live-cell therapies that introduce biological complexity, variability, and immunogenic risk, Cell Factor is a clinically engineered, DNA-free formulation that provides isolated signaling factors with standardized potency across every batch.
Traditional stem cell therapies are “the factory” living cells with donor-dependent composition, regulatory classification as drugs or biologics, and inherent cellular variability. Cell Factor is “the product” a non-cellular, shelf-stable foundation that resets cellular receptors and restores signaling precision without the complications of live biology.
This approach delivers over 400 growth factors and extracellular vesicles (exosomes) that optimize cellular communication pathways. By clearing inflammatory noise and re-establishing receptor sensitivity, Cell Factor creates an environment where your body’s repair mechanisms and any additional therapies can function at peak efficiency.
Published research in Biomolecules (2024) confirms that acellular therapies provide “comparable regenerative potential” to stem cell-based therapies while avoiding limitations like tumor formation risk, immune rejection, and complex regulatory hurdles. Cell Factor holds FDA Section 361 tissue classification not classified as a drug with minimal immunogenic profile.
At Hydration By Lisa, we integrate Cell Factor with our various wellness treatments to amplify results and accelerate healing. With multiple administration methods available for your convenience, Cell Factor represents the next evolution in regenerative medicine. Cell Factor can be administered IV, as an injection, or intranasal. Administration method and treatment plan will be determined based on your personal consultation.
The Cell Factor Advantage
Experience regenerative longevity and cellular optimization protocols designed for performance, resilience, and long-term vitality.
DNA-Free Safety
Clinically Validated
Superior Potency
FDA Section 361 Classification
Enhanced Penetration
Shelf-Stable Formulation
The 3-Phase
Cellular Optimization Protocol
Cell Factor works through a clinically designed sequence: resetting inflammatory baseline, amplifying regenerative therapies, and maintaining long-term signaling integrity.
Phase 1: Inflammatory Reset
The primary objective is to downregulate systemic inflammation and reverse receptor desensitization caused by chronic stress or peptide saturation. Cell Factor functions as a physiological “clearing of the runway”—calming inflammatory noise that blocks effective cellular
- Cytokine Suppression : Downregulates inflammatory signaling (IL-1β, IL-6, TNF-α)
- IL-10 Upregulation : Increases anti-inflammatory cytokines for systemic balance
- Receptor Sensitivity : Restores receptor responsiveness and cellular homeostasis
- NRF2 Pathway : Clears oxidative stress via NRF2 pathway activation
By re-establishing homeostasis and restoring receptor sensitivity, this phase prepares the cellular environment to receive and process downstream regenerative signals, ensuring subsequent therapies are not wasted on a non-responsive system.
Phase 2: Regenerative Acceleration
Once the inflammatory baseline is reset, the protocol shifts toward active tissue repair and mitochondrial optimization. Cell Factor acts as an amplification layer—because cellular receptors have regained their sensitivity, targeted therapies act with significantly higher efficacy.
- Therapy Amplification : GLP-1 agonists, peptides, and growth factors become “accelerants”
- ECM Production Enhanced collagen (+44%), elastin (+68%), hyaluronic acid (+113%)
- Angiogenesis : VEGF/HIF-1α pathway activation for new vessel formation
- Mitochondrial Function : Enhanced energy production and metabolic efficiency
Phase 3: Sustained Optimization
Regeneration is not a single event but a sustained state of balance. This phase focuses on maintaining the signaling integrity established during the reset, preventing re-accumulation of inflammatory dysfunction.
- Maintenance Dosing : Periodic treatments preserve receptor sensitivity
- Energy Production Sustained mitochondrial function and output
- Tissue Repair : Long-term process efficiency and quality
- Longevity Platform: Durable resilience against age-related decline
Cellular Delivery Mechanism
- Nanoscale Delivery : 30-150 nm messengers with superior tissue penetration
- 400+ Growth Factors MicroRNAs and bioactive molecules in each treatment
- Multi-Pathway Activation: NF-κB, VEGF, MAPK, AKT, STAT3, Wnt/β-catenin
- Immediate Bioavailability: No cell viability dependency required
Cell Factor vs. PRP
Both therapies harness regenerative potential, but Cell Factor delivers superior potency, consistency, and safety backed by comparative clinical research.
| Feature | Cell Factor (Exosomes) | PRP(Platelet-Rich Plasma) |
|---|---|---|
| Growth Factors | 400+ | 7-25 |
| Standardization | Consistent, off-the-shelf formulation | Variable, patient-dependent quality |
| Age Dependency | No—consistent potency regardless of age | Yes—decreases with patient age |
| Particle Size | 30-150 nm (nanoscale) | Larger (cellular components) |
| Tissue Penetration | Superior—crosses blood-brain barrier | Limited penetration |
| DNA Content | DNA-free (zero tumor risk) | Contains cellular DNA |
| Regulatory Classification | FDA Section 361 Tissue (not a drug) | Autologous procedure (minimal regulation) |
| Stability & Storage | Shelf-stable, lyophilized formulation | Must be prepared fresh, immediate use only |
| Preparation | Ready-to-use, no phlebotomy or centrifugation | Requires blood draw and processing |
| Treatment Time | Faster office visit | Longer (includes blood processing) |
| Hair Restoration Results | Significant improvement after single session | 5-6 sessions over 6-16 months |
| Clinical Evidence | 77 registered clinical trials; rapidly growing | Well-established (longer track record) |
Cell Factor vs. Traditional
Stem Cell Therapy
Both approaches leverage stem cell biology, but Cell Factor’s acellular technology eliminates the risks and limitations of living cell transplantation. Research published in Biomolecules (2024) confirms acellular therapies provide “comparable regenerative potential” with superior safety and practicality.
| Feature | Cell Factor (Acellular) | Traditional Stem Cells (Cellular) |
|---|---|---|
| DNA Content | DNA-free (zero tumor risk) | Contains living DNA (replicating cells) |
| Tumor Formation Risk | None—acellular, non-replicating | Risk of uncontrolled proliferation, especially with iPSCs |
| Immune Rejection | None—non-immunogenic | Possible rejection requiring immunosuppression |
| Cell Viability Required | No—bioactive factors work immediately | Yes—cells must survive, engraft, and differentiate |
| Storage & Availability | Shelf-stable, lyophilized off-the-shelf formulation | Complex cryopreservation; viability concerns |
| Standardization | Clinically engineered—standardized potency every batch | Variable based on donor, culture conditions |
| Manufacturing | Scalable production; lower cost | Expensive GMP facilities; complex expansion |
| Regulatory Classification | FDA Section 361 Tissue (not a drug or biologic) | Classified as drugs/biologics—extensive regulatory hurdles |
| Tissue Penetration | Superior—30-150 nm nanoscale size | Limited—cells are micron-sized (10-30 µm) |
| Blood-Brain Barrier | Can cross BBB for neuroprotection | Cannot cross BBB |
| Mechanism of Action | Paracrine signaling (secreted factors) | Engraftment, differentiation, paracrine signaling |
| Ethical Concerns | None | Potential issues with embryonic stem cells |
| Preparation Time | Ready-to-use immediately | May require weeks of culture/expansion |
| Clinical Evidence | 77 clinical trials; rapidly expanding | Extensive but mixed results; engraftment challenges |
Cell Factor FAQ
What is Cell Factor?
How does Cell Factor differ from traditional stem cell therapy?
Is Cell Factor FDA-approved?
What conditions can Cell Factor treat?
How is Cell Factor administered?
How many treatments will I need?
Is Cell Factor safe?
When will I see results?
Can Cell Factor be combined with other treatments?
How does Cell Factor compare to PRP?
Cell Factor® Administration Options
A Personalized Guide to Choosing the Right Experience for You
Cell Factor is an advanced regenerative therapy designed to support cellular communication, repair, and optimization. Each administration route offers a unique experience and benefit profile. Many clients choose a single option, while others select a combination for a more comprehensive, concierge-level approach.
Intravenous (IV) Administration
IV administration delivers Cell Factor directly into the bloodstream for maximum absorption and immediate systemic impact. This option creates a powerful foundational reset and is often selected as the starting point for therapy. Ideal for clients seeking whole-body rejuvenation, metabolic and mitochondrial support, inflammation reduction, and a noticeable boost in vitality.
Subcutaneous (SQ) Administration
Subcutaneous injections provide a slow, steady release of Cell Factor through the lymphatic system. This approach offers sustained regenerative signaling over time and is well suited for maintenance and long-term support. Ideal for clients who prefer consistent weekly or bi-weekly support, convenience, and ongoing cellular optimization.
Intranasal (IN) Administration
Intranasal delivery allows Cell Factor to be absorbed through specialized nasal pathways, offering both systemic benefits and direct neurological support. Ideal for clients focused on mental clarity, focus, mood, sleep quality, stress resilience, and cognitive wellness.
The Luxury of Combination Therapy
For clients seeking the highest level of regenerative support, combining administration routes offers a refined and comprehensive experience. This approach mirrors the body’s natural signaling pathways and allows each route to complement the others seamlessly.
Combination therapy may include IV for immediate activation, SQ for sustained repair, and IN for targeted neurological enhancement. Your treatment plan will always be personalized based on your goals, lifestyle, and health history. We will guide you through each option and help you select the approach that best aligns with your vision for longevity and wellness.
Book Your Session
For clients seeking advanced wellness, recovery, and cellular optimization.
